SI1642905T1 - Imunogeni T-pomagalni epitop iz humanega tumornega antigena in imunoterapevtski postopki, ki uporabljajo navedeni epitop - Google Patents

Imunogeni T-pomagalni epitop iz humanega tumornega antigena in imunoterapevtski postopki, ki uporabljajo navedeni epitop

Info

Publication number
SI1642905T1
SI1642905T1 SI200431004T SI200431004T SI1642905T1 SI 1642905 T1 SI1642905 T1 SI 1642905T1 SI 200431004 T SI200431004 T SI 200431004T SI 200431004 T SI200431004 T SI 200431004T SI 1642905 T1 SI1642905 T1 SI 1642905T1
Authority
SI
Slovenia
Prior art keywords
epitopes
tumour
present
immunotherapeutic methods
relates
Prior art date
Application number
SI200431004T
Other languages
English (en)
Inventor
Hans-Georg Rammensee
Toni Weinschenk
Jorn Dengjel
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of SI1642905T1 publication Critical patent/SI1642905T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI200431004T 2004-10-02 2004-10-02 Imunogeni T-pomagalni epitop iz humanega tumornega antigena in imunoterapevtski postopki, ki uporabljajo navedeni epitop SI1642905T1 (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04023546A EP1642905B1 (en) 2004-10-02 2004-10-02 Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes

Publications (1)

Publication Number Publication Date
SI1642905T1 true SI1642905T1 (sl) 2009-04-30

Family

ID=34926825

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200431004T SI1642905T1 (sl) 2004-10-02 2004-10-02 Imunogeni T-pomagalni epitop iz humanega tumornega antigena in imunoterapevtski postopki, ki uporabljajo navedeni epitop
SI200530786T SI1794190T1 (sl) 2004-10-02 2005-09-09 Imunogeni T-pomagalni epitopi iz humanih tumornih antigenov in imunoterapevtski postopki, ki uporabljajo navedene epitope

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200530786T SI1794190T1 (sl) 2004-10-02 2005-09-09 Imunogeni T-pomagalni epitopi iz humanih tumornih antigenov in imunoterapevtski postopki, ki uporabljajo navedene epitope

Country Status (11)

Country Link
US (1) US8067529B2 (sl)
EP (2) EP1642905B1 (sl)
JP (2) JP2008514208A (sl)
AT (2) ATE421533T1 (sl)
AU (1) AU2005291660B2 (sl)
CA (1) CA2583065A1 (sl)
DE (2) DE602004019215D1 (sl)
ES (2) ES2319286T3 (sl)
PL (2) PL1642905T3 (sl)
SI (2) SI1642905T1 (sl)
WO (1) WO2006037421A2 (sl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0609121D0 (en) * 2006-05-09 2006-06-21 Univ Birmingham Peptide Therapy
US20090004213A1 (en) 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
NZ582823A (en) 2007-07-27 2012-04-27 Immatics Biotechnologies Gmbh Composition of tumour-associated peptides and related anti-cancer vaccine
TW200932260A (en) * 2007-11-28 2009-08-01 Oncotherapy Science Inc STAT3 epitope peptides
TW201000119A (en) * 2008-06-10 2010-01-01 Oncotherapy Science Inc MYBL2 epitope peptides and vaccines containing the same
AU2016204712B2 (en) * 2008-10-01 2018-03-01 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors including neuronal and brain tumors
PL2172211T3 (pl) * 2008-10-01 2015-05-29 Immatics Biotechnologies Gmbh Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka
DK2342220T3 (da) * 2008-10-06 2021-08-09 Univ British Columbia Metoder og systemer til forudsigelse af misfoldede proteinepitoper
WO2011073215A2 (en) 2009-12-14 2011-06-23 Immatics Biotechnologies Gmbh Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
GB201004575D0 (en) 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
GB201009222D0 (en) 2010-06-02 2010-07-21 Immatics Biotechnologies Gmbh Improved cancer therapy based on tumour associated antigens derived from cyclin D1
SG191154A1 (en) 2010-12-14 2013-07-31 Immatics Biotechnologies Gmbh Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
EP2970496B1 (en) * 2013-03-12 2018-07-18 Institute of Arthritis Research LLC Immunologically active polypeptide
MY191939A (en) * 2013-08-05 2022-07-19 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors, such as lung cancer, including nsclc
ES2902835T3 (es) 2014-01-09 2022-03-30 Hadasit Med Res Service Composiciones celulares mejoradas y métodos para la terapia contra el cáncer
US10293035B2 (en) 2014-03-28 2019-05-21 University Of Washington Through Its Center For Commercialization Breast and ovarian cancer vaccines
ES2749073T3 (es) * 2014-04-01 2020-03-19 Inst Nat Sante Rech Med Un péptido donante aislado derivado de MHC y su uso
ES2702676T3 (es) * 2014-04-01 2019-03-04 Inst Nat Sante Rech Med Péptido de donante aislado derivado de MHC y usos del mismo
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
ZA201707555B (en) * 2015-06-25 2018-11-28 Immatics Biotechnologies Gmbh Novel cell epitopes and combination of cell epitopes for use in the immuno-therapy of myeloma and other cancers
MY198087A (en) 2015-10-05 2023-07-31 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201607535D0 (en) * 2016-04-29 2016-06-15 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201521746D0 (en) 2015-12-10 2016-01-27 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
MA45491A (fr) * 2016-06-27 2019-05-01 Juno Therapeutics Inc Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
WO2019155474A1 (en) 2018-02-12 2019-08-15 Hadasit Medical Research Services & Development Ltd. Modulation of slamf6 splice variants for cancer therapy
US20220064260A1 (en) * 2018-12-14 2022-03-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8+cd45rclow tregs
AU2022233019A1 (en) * 2021-03-11 2023-09-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Tumor neoantigenic peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020796A2 (en) * 1991-05-16 1992-11-26 Cold Spring Harbor Laboratory D-type cyclin and uses related thereto
AUPM322393A0 (en) 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
US5912167A (en) * 1995-06-06 1999-06-15 Wisconsin Alumni Research Foundation Autocatalytic cleavage site and use thereof in a protein expression vector
AU1394497A (en) 1996-01-17 1997-08-11 Imperial College Innovations Limited Immunotherapy using cytotoxic t lymphocytes (ctl)
GB9823897D0 (en) * 1998-11-02 1998-12-30 Imp College Innovations Ltd Immunotherapeutic methods and molecules
JP2005525788A (ja) * 2001-09-28 2005-09-02 インサイト・ゲノミックス・インコーポレイテッド 酵素
US20030194704A1 (en) * 2002-04-03 2003-10-16 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
DE10225144A1 (de) * 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
EP1369482A1 (en) * 2002-06-07 2003-12-10 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Target genes for the diagnosis and treatment of cancer
US20090203639A1 (en) 2005-04-15 2009-08-13 Oncomethylome Sciences, Inc. Methylation Markers for Diagnoses and Treatment of Cancers

Also Published As

Publication number Publication date
JP2008514208A (ja) 2008-05-08
JP2011200231A (ja) 2011-10-13
PL1642905T3 (pl) 2009-04-30
EP1794190A2 (en) 2007-06-13
EP1794190B1 (en) 2009-08-12
ES2328945T3 (es) 2009-11-19
PL1794190T3 (pl) 2010-01-29
ATE439375T1 (de) 2009-08-15
ATE421533T1 (de) 2009-02-15
EP1794190B9 (en) 2010-05-19
US20090317428A1 (en) 2009-12-24
AU2005291660A1 (en) 2006-04-13
DE602004019215D1 (de) 2009-03-12
ES2319286T3 (es) 2009-05-06
WO2006037421A2 (en) 2006-04-13
CA2583065A1 (en) 2006-04-13
WO2006037421A3 (en) 2006-06-29
EP1642905B1 (en) 2009-01-21
SI1794190T1 (sl) 2009-12-31
AU2005291660B2 (en) 2010-02-18
US8067529B2 (en) 2011-11-29
EP1642905A1 (en) 2006-04-05
DE602005015990D1 (de) 2009-09-24

Similar Documents

Publication Publication Date Title
PL1794190T3 (pl) Immunogenne epitopy komórek pomocniczych T pochodzące z ludzkich antygenów nowotworowych oraz sposoby stosowania tych epitopów w immunoterapii
HK1220709A1 (zh) 混雜地結合於人類白細胞抗原 類分子的腫瘤相關肽
RS51893B (en) TUMOR-ASSOCIATED PEPTIDES CONCERNING HUMAN LEUCOCYTIC ANTIGEN (HLA) CLASS I OR II MOLECULES AND ANTI-TUMOR VACCINE BASED ON THEM